ATE122561T1 - Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält. - Google Patents

Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält.

Info

Publication number
ATE122561T1
ATE122561T1 AT91830083T AT91830083T ATE122561T1 AT E122561 T1 ATE122561 T1 AT E122561T1 AT 91830083 T AT91830083 T AT 91830083T AT 91830083 T AT91830083 T AT 91830083T AT E122561 T1 ATE122561 T1 AT E122561T1
Authority
AT
Austria
Prior art keywords
methylthiopropionyl
carnitine
cardiovascular system
pharmaceutical preparation
preparation acting
Prior art date
Application number
AT91830083T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE122561T1 publication Critical patent/ATE122561T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91830083T 1990-03-15 1991-03-11 Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält. ATE122561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47759A IT1240799B (it) 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Publications (1)

Publication Number Publication Date
ATE122561T1 true ATE122561T1 (de) 1995-06-15

Family

ID=11262331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91830083T ATE122561T1 (de) 1990-03-15 1991-03-11 Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält.

Country Status (9)

Country Link
US (1) US5173508A (de)
EP (1) EP0448523B1 (de)
JP (1) JPH04217656A (de)
AT (1) ATE122561T1 (de)
DE (1) DE69109721T2 (de)
DK (1) DK0448523T3 (de)
ES (1) ES2072591T3 (de)
HK (1) HK1005565A1 (de)
IT (1) IT1240799B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
EP0951909B2 (de) 1998-03-19 2010-10-20 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Kombinierte Zusammensetzung bestehend aus L-Karnitin oder L-Alkanoylkarnitin, einem Glycosaminoglycan und/oder einem seiner Bestandteile

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1170862B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1177874B (it) * 1984-07-04 1987-08-26 Sigma Tau Ind Farmaceuti Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono

Also Published As

Publication number Publication date
IT9047759A1 (it) 1991-09-15
ES2072591T3 (es) 1995-07-16
EP0448523B1 (de) 1995-05-17
IT1240799B (it) 1993-12-17
US5173508A (en) 1992-12-22
DK0448523T3 (da) 1995-06-06
IT9047759A0 (it) 1990-03-15
JPH04217656A (ja) 1992-08-07
EP0448523A2 (de) 1991-09-25
HK1005565A1 (en) 1999-01-15
DE69109721D1 (de) 1995-06-22
DE69109721T2 (de) 1995-10-26
EP0448523A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
DE69407869T2 (de) Künstliches, in einen Herzventrikel implantiertes Hilfsherz
CA2275225A1 (en) Cardiac lead arrangement
CA2275221A1 (en) Side access "over the wire" pacing lead
TR200201059T2 (tr) Kardiyak arritmialarının tedavisinde kullanışlı yeni oksabispidin bileşimleri
DE3882250D1 (de) Herzdefibrillator.
DE3883651T2 (de) Herzschlagabhängiger Schrittmacher.
IT1238542B (it) Elettrocatetere retrattile tripolare ad ancoraggio endocavitario attivo per la stimolazione cardiaca.
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
ATE122561T1 (de) Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält.
RU93044489A (ru) Производные хиноксалина, их получение, лекарственные средства на их основе
DE69110937T2 (de) Herzschrittmacher zur Beendung von Herzarrhythmia.
DE69302544T2 (de) 2-amino-1,2,3,4-tetrahydronaphthalen derivate mit wirkung auf das kardiovasculäre system, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen
IT1275935B1 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
Minzioni et al. Right atrial isolation associated with atrial septal closure in patients with atrial septal defect and chronic atrial fibrillation
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
RU97108900A (ru) Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
Hernández-Pieretti et al. Sick sinus syndrome in chronic Chagas heart disease
Khan Wolff-Parkinson-White syndrome: pseudo myocardial infarction and pseudo ventricular hypertrophy patterns on electrocardiogram
ITFI910180A1 (it) Sistema di defibrillazione cardiaca per limitare l'energia erogata al paziente
谷川宗生 Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome
ITTO911015A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo.
RU98101528A (ru) Способ повышения эффективности антиаритмической терапии
Hordof et al. Hemodynamic assessment of total anomalous pulmonary venous connection (TAPVC) following correction during infancy
Holman et al. Evaluation of acute myocardial infarction with technetium-99m-tetracycline infarct imaging

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee